{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:47:02Z","timestamp":1791190022474,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jaci.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T09:47:21Z","timestamp":1398764841000},"page":"1626-1634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology"],"prefix":"10.1016","volume":"133","author":[{"given":"Saakshi","family":"Khattri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Shemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Rozenblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Czarnowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Finney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gilleaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sullivan-Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de Guzman Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2014.03.003_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.iac.2010.05.004","article-title":"Quality-of-life outcomes and measurement in childhood atopic dermatitis","volume":"30","author":"Chamlin","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2014.03.003_bib2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2011.01.054","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014part II: immune cell subsets and therapeutic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/14712598.2013.758708","article-title":"New era of biologic therapeutics in atopic dermatitis","volume":"13","author":"Guttman-Yassky","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaci.2014.03.003_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014part I: clinical and pathologic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib5","first-page":"26","article-title":"The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids?","volume":"176","author":"Fartasch","year":"1992","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.jaci.2014.03.003_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?","volume":"96","author":"Imokawa","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4168\/aair.2012.4.1.12","article-title":"Epidermal barrier in atopic dermatitis","volume":"4","author":"Kim","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2014.03.003_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","article-title":"Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis","volume":"132","author":"Suarez-Farinas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib10","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib11","doi-asserted-by":"crossref","first-page":"e31465","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2014.03.003_bib12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A\u00a0in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1398-9995.2009.02054.x","article-title":"Low-dose cyclosporine A\u00a0therapy increases the regulatory T cell population in patients with atopic dermatitis","volume":"64","author":"Brandt","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.03.003_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2567.2003.01585.x","article-title":"Immunomodulatory effects of cyclosporin A\u00a0on human peripheral blood dendritic cell subsets","volume":"108","author":"Tajima","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2014.03.003_bib15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.jid.5701244","article-title":"Calcineurin activity and inhibition in skin and epidermal cell cultures","volume":"128","author":"Smit","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib16","doi-asserted-by":"crossref","first-page":"32440","DOI":"10.1074\/jbc.M112.385245","article-title":"The calcium\/calcineurin pathway promotes hemidesmosome stability through inhibition of \u00df4 integrin phoshorylation","volume":"287","author":"Kashyap","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.03.003_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2008.01.006","article-title":"Calcineurin\/NFAT dependent regulation of 230 kDa bullous pemphigoid antigen (BPAG1) gene expression in normal human epidermal keratinocytes","volume":"51","author":"Aizu","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2014.03.003_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1610-0387.2008.06834.x","article-title":"Systemic therapeutic options for severe atopic dermatitis","volume":"7","author":"BuBmann","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2014.03.003_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1468-3083.2006.01877.x","article-title":"Efficacy and safety of long-term treatment with cyclosporin A\u00a0for atopic dermatitis","volume":"21","author":"Hijnen","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2014.03.003_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2014.03.003_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.1991.tb03280.x","article-title":"Cyclosporin A\u00a0in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions","volume":"124","author":"Munro","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1995.tb08633.x","article-title":"Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy","volume":"132","author":"Granlund","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00015559850135814","article-title":"Long-term follow-up of eczema patients treated with cyclosporine","volume":"78","author":"Granlund","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2014.03.003_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2009.07.056","article-title":"Cyclosporin A\u00a0reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis","volume":"124","author":"Hijnen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2010.04.032","article-title":"Low-dose, but not high-dose, cyclosporin A\u00a0promotes regulatory T-cell induction, expansion, or both","volume":"126","author":"Baumgrass","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1684\/ejd.2011.1470","article-title":"Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis","volume":"21","author":"Otsuka","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2133.2001.03948.x","article-title":"A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy","volume":"144","author":"Farrell","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2003.12.007","article-title":"Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis","volume":"113","author":"Hijnen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000053836","article-title":"Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis","volume":"125","author":"Bunikowski","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2001.012004216.x","article-title":"Low-dose cyclosporin A\u00a0microemulsion in children with severe atopic dermatitis: clinical and immunological effects","volume":"12","author":"Bunikowski","year":"2001","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdermsci.2004.02.008","article-title":"Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis","volume":"35","author":"Furukawa","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2014.03.003_bib32","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1074\/jbc.M111.286492","article-title":"Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a","volume":"287","author":"Rudloff","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.03.003_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib34","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.3390\/ijms14048456","article-title":"Effects of narrow band UVB (311 nm) irradiation on epidermal cells","volume":"14","author":"Reigh","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2014.03.003_bib35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib36","unstructured":"R Software. Available at: http:\/\/www.Rproject.org. Accessed April 5, 2014."},{"key":"10.1016\/j.jaci.2014.03.003_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2105-6-294","article-title":"Harshlight: a \u201ccorrective make-up\u201d program for microarray chips","volume":"6","author":"Suarez-Farinas","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2014.03.003_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","volume":"99","author":"Wu","year":"2004","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jaci.2014.03.003_bib39","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.4049\/jimmunol.173.11.6712","article-title":"IL-19 induced Th2 cytokines and was upregulated in asthma patients","volume":"173","author":"Liao","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib40","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2012.11.010","article-title":"Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB","volume":"131","author":"Suarez-Farinas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/all.12184","article-title":"Immunology of atopic eczema: overcoming the Th1\/Th2 paradigm","volume":"68","author":"Eyerich","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.03.003_bib44","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"242","author":"Boguniewicz","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2014.03.003_bib46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201dT cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib48","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","article-title":"IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response","volume":"123","author":"Eyerich","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.03.003_bib50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1346-8138.2011.01462.x","article-title":"Interleukin-17- and protease-activated receptor 2-mediated production of CXCL1 and CXCL8 modulated by cyclosporine A, vitamin D3 and glucocorticoids in human keratinocytes","volume":"39","author":"Takei-Taniguchi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00403-010-1099-3","article-title":"Cyclosporin A\u00a0induces the unfolded protein response in keratinocytes","volume":"303","author":"Hibino","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2014.03.003_bib52","unstructured":"Pilot study of ustekinumab for subjects with chronic atopic dermatitis. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01806662. Accessed April 5, 2014."},{"key":"10.1016\/j.jaci.2014.03.003_bib53","unstructured":"A randomized placebo-controlled study to determine the safety, tolerability, pharmacodynamics and clinical efficacy of ILV-094 (an IL-22 antibody) administered intravenously to subjects with atopic dermatitis (AD). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01941537. Accessed April 5, 2014."},{"key":"10.1016\/j.jaci.2014.03.003_bib54","unstructured":"Study to determine the safety and effectiveness of dupilumab (REGN668\/SAR231893) for treatment of atopic dermatitis (AD). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01979016. Accessed April 5, 2014."}],"updated-by":[{"DOI":"10.1016\/j.jaci.2014.07.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914003571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914003571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T13:14:42Z","timestamp":1668604482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674914003571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0091674914003571"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2014.03.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718371356.793499552","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2014.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}